AngioDynamics (NASDAQ:ANGO) issued its earnings results on Thursday. The medical instruments supplier reported $0.16 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.16, Bloomberg Earnings reports. AngioDynamics had a net margin of 1.64% and a return on equity of 4.83%. The company had revenue of $86.70 million during the quarter, compared to analysts’ expectations of $88.15 million. During the same period last year, the company posted $0.19 earnings per share. The firm’s quarterly revenue was down 2.6% compared to the same quarter last year.
AngioDynamics (NASDAQ:ANGO) opened at $16.41 on Thursday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.48 and a current ratio of 2.34. AngioDynamics has a 12 month low of $14.80 and a 12 month high of $18.85. The firm has a market cap of $615.36, a P/E ratio of 109.41, a PEG ratio of 1.72 and a beta of 1.04.
A number of brokerages have issued reports on ANGO. TheStreet cut shares of AngioDynamics from a “b-” rating to a “c” rating in a report on Tuesday. KeyCorp reissued a “hold” rating on shares of AngioDynamics in a research note on Friday, September 29th. Canaccord Genuity reissued a “hold” rating and set a $17.00 price objective on shares of AngioDynamics in a research note on Sunday, October 8th. Finally, Zacks Investment Research raised shares of AngioDynamics from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a research note on Tuesday, October 3rd. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $18.60.
AngioDynamics Company Profile
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.